Skip to content
  • Sunday, 26 July 2026
  • 5:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option
Pharmaceutical R&D

Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option

Teuku Ryan May 14, 2026 0

On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…

Read More
Stem Cell & Regenerative Medicine

Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging

Dwi Wanna May 8, 2026 0

The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy…

Read More
Neuroscience & Brain Research

UC San Francisco Researchers Identify FTL1 Protein as Key Driver of Hippocampal Aging and Memory Loss in New Study

Rifan Muazin May 6, 2026 0

The aging process has long been recognized as the primary risk factor for a wide array of neurodegenerative conditions, with…

Read More
Neuroscience & Brain Research

Internalized Stress and Feelings of Hopelessness Linked to Accelerated Memory Loss Among Older Chinese Americans According to Rutgers Study

Rifan Muazin May 5, 2026 0

New research from the Rutgers Institute for Health, Health Care Policy and Aging Research has identified a significant correlation between…

Read More
Laboratory Automation & Robotics

Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial

Lana Keisha May 4, 2026 0

Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…

Read More
Neuroscience & Brain Research

Brain Immune System Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients

Rifan Muazin May 4, 2026 0

The decline of the olfactory sense has long been observed as a precursor to the cognitive deterioration associated with Alzheimer’s…

Read More
Pharmaceutical R&D

Eli Lilly Soars Past Expectations on Unabated Weight-Loss Drug Demand, Raises Full-Year Forecast

Teuku Ryan May 2, 2026 0

Eli Lilly and Company has once again demonstrated its formidable market power, reporting first-quarter 2026 sales that significantly surpassed analyst…

Read More
Pharmaceutical R&D

Eliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions

Teuku Ryan May 1, 2026 0

The pharmaceutical industry is bracing for one of the most significant patent cliff events in its history as Eliquis, the…

Read More
Stem Cell & Regenerative Medicine

Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging

Dwi Wanna May 1, 2026 0

The pharmaceutical landscape of the 21st century has been fundamentally altered by the advent of glucagon-like peptide-1 (GLP-1) receptor agonists.…

Read More
Neuroscience & Brain Research

Internalized Stress Linked to Heightened Risk of Memory Loss in Older Chinese Americans According to Rutgers Study

Rifan Muazin Apr 28, 2026 0

New research from Rutgers Health suggests that the psychological tendency to turn stress inward—a phenomenon often characterized by feelings of…

Read More

Posts pagination

1 … 3 4 5 … 8
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS saysRIKEN Physicists Propose Breakthrough Method for Robust One-Way Quantum Synchronization of PhononsScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyEClinical Solutions study models 241% ROI from AI-powered clinical trial data platform
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ